Bedrocan’s recent collapse, which has endangered the supply of life-saving epilepsy medicine for dozens of patients across Europe, could soon be revived under a new entity.
Policy, markets and medical news from the newsroom, in one email a week.
Sign up freeOver the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with a greater variety than ever before.
Read the analysisEurope’s largest medical cannabis market, tracked by our newsroom week by week.
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
countries we track allow adult-use cannabis. 25 run established medical programmes.
Explore the mapCannabis stocks43listed cannabis stocks tracked across MSOs, LPs, ancillary, pharma, REITs and ETFs.
Open the trackerUS reschedulingSince 197030 dated milestones in the federal process, from the Controlled Substances Act to today.
Follow the timeline
